EMPower: Electronic Media Powering Positive Health Changes in Youth
Not Applicable
Completed
- Conditions
- PrehypertensionObesityHypertensionOverweightHypertrophy, Left Ventricular
- Registration Number
- NCT02444689
- Lead Sponsor
- Johns Hopkins University
- Brief Summary
The purpose of this study is to evaluate the effectiveness of a technology-based behavioral Healthy Lifestyle intervention on adiposity (body mass index z-score), blood pressure (mean clinic systolic BP), and heart size (LVM) in comparison to standard care.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 91
Inclusion Criteria
- Overweight or Obese
- Speaks English
Exclusion Criteria
- No smart phone / smart phone data plan
- Not willing to send/ receive text messages or download and use the study applications
- Neurological impairment/ developmental delay
- New / changes in anti-hypertensive medication or medication known to affect blood pressure within the last 6 months
- Prior diagnosis of congenital heart disease or cancer
- Pregnancy
- Taking medication with weight gain as a side effect
- Taking medications for weight loss/ participation in another weight loss program
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Change in adiposity as measured by change in BMI z-score 6 months from date of randomization
- Secondary Outcome Measures
Name Time Method Change in clinic systolic blood pressure 6 months from date of randomization Change in left ventricular mass index 6 months from date of randomization
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the EMPower intervention's impact on adiposity and left ventricular hypertrophy in youth?
How does the EMPower program compare to traditional behavioral interventions in reducing blood pressure and BMI z-scores in prehypertensive adolescents?
Are there specific biomarkers that correlate with improved cardiovascular outcomes following the EMPower intervention in obese youth?
What adverse events are associated with technology-based behavioral interventions for obesity and hypertension in pediatric populations?
What combination therapies or digital health tools show promise alongside EMPower for managing left ventricular hypertrophy in overweight youth?
Trial Locations
- Locations (1)
Johns Hopkins University
🇺🇸Baltimore, Maryland, United States
Johns Hopkins University🇺🇸Baltimore, Maryland, United States